Tarbox Family Office’s Alnylam Pharmaceuticals ALNY Stock Holding History

Tarbox Family Office’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20	Closed	-$3K	–	150
2022 Q1	$3K	Hold	20	–	–	﹤0.01%	647
2021 Q4	$3K	Hold	20	–	–	﹤0.01%	736
2021 Q3	$4K	Hold	20	–	–	﹤0.01%	679
2021 Q2	$3K	Sell	20 -11	-35%	-$1.61K	﹤0.01%	770
2021 Q1	$4K	Hold	31	–	–	﹤0.01%	608
2020 Q4	$4K	Hold	31	–	–	﹤0.01%	569
2020 Q3	$5K	Hold	31	–	–	﹤0.01%	470
2020 Q2	$5K	Hold	31	–	–	﹤0.01%	467
2020 Q1	$3K	Buy	31 +11	+55%	+$1.27K	﹤0.01%	505
2019 Q4	$2K	Hold	20	–	–	﹤0.01%	755
2019 Q3	$2K	Hold	20	–	–	﹤0.01%	689
2019 Q2	$1K	Hold	20	–	–	﹤0.01%	880
2019 Q1	$2K	Hold	20	–	–	﹤0.01%	482
2018 Q4	$1K	Hold	20	–	–	﹤0.01%	534
2018 Q3	$2K	Hold	20	–	–	﹤0.01%	490
2018 Q2	$2K	Hold	20	–	–	﹤0.01%	477
2018 Q1	$2K	Hold	20	–	–	﹤0.01%	486
2017 Q4	$3K	Hold	20	–	–	﹤0.01%	435
2017 Q3	$2K	Hold	20	–	–	﹤0.01%	472
2017 Q2	$2K	Hold	20	–	–	﹤0.01%	458
2017 Q1	$1K	Hold	20	–	–	﹤0.01%	522
2016 Q4	$1K	Buy	+20	New	+$837	﹤0.01%	487
2016 Q2	–	Sell	-10	Closed	-$1K	–	556
2016 Q1	$1K	Buy	+10	New	+$665	﹤0.01%	482

Other funds holding ALNY

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tarbox Family Office's ALNY Position: Q2 2022 in Review

Tarbox Family Office sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2022, closing a stake of 20 shares — an estimated $3K sold.

Tarbox Family Office first reported a position in ALNY in Q1 2016 and held it in 23 quarters. The position peaked at $5K in Q3 2020. 423 funds tracked by Wall St. Rank hold ALNY as of Q2 2022.

Tarbox Family Office reported no remaining Alnylam Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
Tarbox Family Office sold 20 Alnylam Pharmaceuticals shares in Q2 2022, an estimated $3K.
Tarbox Family Office first reported a position in Alnylam Pharmaceuticals in Q1 2016 and held it in 23 quarters.
Tarbox Family Office's Alnylam Pharmaceuticals position peaked at $5K in Q3 2020.
423 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2022.

Based on Tarbox Family Office's 13F filing for Q2 2022, filed 19 Jul 2022.